A top UCLA immunologist, Dr. Yang, warns of the potential impact of funding disruptions in biomedical research caused by a Trump administration memo. He highlights the critical role of National Institutes of Health (NIH) funding in groundbreaking discoveries and innovative treatments. Dr. Yang's lab, reliant on NIH grants, faces uncertainty due to the funding freeze. He emphasizes the importance of scientific autonomy and the need for a clear understanding of the memo's implications for research.
In an exclusive interview, one of UCLA 's top scientists spoke out about what the disruptions in funding could mean to you and to science. \In just the last few years, we've experienced the fruits of biomedical research. Gene editing technology that can lead to potential cures for cancer and sickle cell anemia, advances in immunotherapy and the advent of the mRNA vaccines. These are all breakthroughs that came from National Institutes of Health funding.
But late last month, the Trump administration sent out a memo that could change the face of research. \Having just a few ideas being pursued is not enough,' said Dr. Yang. His work as a renowned immunologist made him a top go-to expert during the COVID-19 pandemic. For the past 25 years, Yang and his colleagues have mapped the inner world of T-cells in our immune system. How they act when challenged by HIV, cancer and transplanted organs. It's foundational research that's contributed to novel therapies. 'All of these innovations that happened in the university setting are what then go down the pipeline and become new treatments,' Yang said. Finding ways to treat disease is Yang's passion, but it requires funding. UCLA provides his lab space, but outside money, mainly from the National Institutes of Health, pays for everything else. His materials and his modest lab staffed with about six people requires a budget of a million dollars annually. Each grant is limited in its run. Yang likens it to his research living paycheck to paycheck. \When he submits a proposal, Yang is competing for part of the NIH's yearly $48 billion in funding. But two weeks ago, a Trump executive order halted the flow of money, leaving his lab in limbo. 'There's really no fat and no storage of money. And if there's a freeze in the spending of your grants it's very disruptive,' he said. This week the NIH announced some funding will return, but Yang wonders how long it will last and how these disruptions could impact patients. From UC President Michael Drake, referring to a memo from the Office of Management and Budget, Drake writes: 'The memo is broad and it is not yet possible to know the full extent of the implications.' He explains that the funding changes need clarification, but writes: 'We do know that it directs each agency to ensure their grants and loan programs are consistent with President Donald Trump's executive orders.' 'Frankly, what's important or what not to research really should be left to the scientists,' said Yang. When it comes to NIH grant approval, a panel of independent scientists decide which proposals should receive funding, not government officials. It's a form of governance that should sound familiar. 'To me it's not a perfect system, but it's very much a democratic system in science,' Yang said. 'And that should be allowed to run unimpeded.
BIOMEDICAL RESEARCH FUNDING DISRUPTIONS NATIONAL INSTITUTES OF HEALTH NIH UCLA IMMUNOLOGY DONALD TRUMP SCIENTIFIC AUTONOMY RESEARCH INNOVATION
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Michigan Dominates UCLA in Big Ten ShowdownMichigan defeated UCLA 94-75 in a Big Ten matchup. Vladislav Goldin led Michigan with a career-high 36 points, while UCLA struggled from beyond the arc, going 2 for 20. The Wolverines' strong shooting and efficient offense proved too much for the Bruins.
Read more »
UCLA Bruins Fall to Michigan Wolverines in Dominant PerformanceThe UCLA Bruins lost a heartbreaking game against the Michigan Wolverines, who shot exceptionally well and controlled the majority of the game. The Bruins struggled to find their offense, particularly from beyond the arc.
Read more »
Dickinson's Career-High Leads Michigan Past UCLAHunter Dickinson scored a career-high 36 points, leading No. 24 Michigan to a 94-75 victory over 22nd-ranked UCLA.
Read more »
Michigan Wolverines Overpower UCLA Bruins in High-Scoring AffairThe Michigan Wolverines defeated the UCLA Bruins in a high-scoring game, snapping the Bruins' eight-game home winning streak. The Wolverines' strong shooting and dominant fourth quarter proved too much for UCLA to overcome.
Read more »
Michigan Dominates UCLA in 94-75 VictoryMichigan defeated UCLA 94-75 in a dominant performance, spearheaded by Vladislav Goldin's 36 points and Tre Donaldson's four three-pointers in the second half. Despite a strong comeback attempt by UCLA, Michigan's strong inside and outside shooting proved too much for the Bruins.
Read more »
Michigan Basketball Dominates UCLA in Road VictoryThe Michigan Wolverines continued their impressive start to the Big Ten season with a decisive 94-75 victory over the UCLA Bruins. Vlad Goldin put on a show with a career-high 36 points, leading the Wolverines to a fourth consecutive win.
Read more »